|
|
| Oncologie > Etude de marché sectorielle |
| Colorectal Cancer (CRC) Therapeutics |
|
|
|
|
€ 3 160,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2006 |
Taille du document : |
387 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 162 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
cancer
|
| Research
focus: |
market definition,market outlook, |
| Geographic
focus: |
france,canada,finland,switzerland,norway,sweden,... |
| |
|
|
|
|
| 162 pages | Octobre 2006 | Anglais
|
|
|
| Main
focus: |
cancer
|
| Research
focus: |
market definition,market outlook, |
| Geographic
focus: |
france,canada,switzerland,finland,mauritius,usa,... |
| |
|
|
|
|
| 92 pages | Février 2008 | Anglais
|
|
|
| Main
focus: |
cancer,oncology,lymphoma,breast cancer,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,france,germany,united kingdom,switzerland,... |
| |
|
|
|
|
| 58 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
cancer,breast cancer,ovarian cancer,life insurance
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
usa,canada,united kingdom |
| |
|
|
|
|
| 58 pages | Décembre 2005 | Anglais
|
|
|
| Main
focus: |
cancer,prostate cancer,oncology,cancer treatment,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
canada,usa,france,united kingdom,japan,germany,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pipeline Insight: Hematological malignancies - Targeted treatments and immunotherapy infuse new blood
219 pages | Avril 2005 |
IntroductionGiven an enhanced understanding of the biological basis for oncogenesis and the benefit of immunotherapy approaches such as Genentech/Roche's Rituxan, it is no surprise that targeted treat |
9 120,00 €
|
| |
| |
MarketWatch: Cancer
30 pages | Juin 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
Stakeholder Opinions: Head and Neck Cancer - Innovatives to Change the Face of Treatment
68 pages | Février 2005 |
IntroductionThe incidence of head and neck cancers is increasing.
Surgery and radiation are employed with curative intent for early stage lesions.
Chemotherapy concurrent with radiation and surg |
3 040,00 €
|
| |
| |
Cytotoxics for Lung Cancer Therapy
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaze a Trail
71 pages | Janvier 2005 |
IntroductionRoche continues to lead the oncology sector, recording oncology sales of $5,719m in 2003.
This sector dominance is predicted to continue between 2004 and 2010, due to Roche's ability to |
3 040,00 €
|
| |
| |
MarketWatch: Cancer
29 pages | Décembre 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
170,00 €
|
| |
| |
MarketWatch: Cancer
31 pages | Février 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
Chinese Markets for Cancer Treatment Drugs
218 pages | Septembre 2002 |
China's demand for cancer treatment drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's e |
2 835,00 €
|
| |
| |
Commercial Insight: Generic Cancer Market - New Legislation and a Wave of Patent Expiries to Transform the Market
179 pages | Décembre 2005 |
IntroductionOver the next 10 years a significant number of key oncology products, some with blockbuster status, will lose patent protection, thus exposing billions of dollars to generic erosion.
Wh |
12 920,00 €
|
| |
| |
CPT Codes and Reimbursement Amount for Selected Tumor Markers for New York State and California
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Colorectal Cancer (CRC) Therapeutics |
|
|
This report analyzes the worldwide markets for Colorectal Cancer Therapeutics in US$ Million. The major product segments analyzed are Cytotoxic Therapies (5-FU (Fluorouracil), Camptosar (Irinotecan), Eloxatin (Oxaliplatin), and Xeloda (Capecitabine), Targeted Therapies (Avastin (bevacizumab), and Erbitux (cetuximab). The report provides separate comprehensive analytics for the United States and Rest of World. Annual forecasts are provided for the period of 2001 through 2010. The report profiles 69 companies including many key and niche players worldwide such as Amgen Inc., Bristol-Myers Squibb, F.Hoffmann-La Roche Ltd., Genentech, Inc., Imclone Systems Inc., Novartis AG, Oxford Biomedica, Pfizer Inc., Sanofi-Aventis, and Schering AG. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
|
|
Colorectal Cancer (CRC) Therapeutics
|
|
|
PPLSEN
|
|
|
|
|
